CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹19,483 Cr | ₹17,763 Cr | ₹17,251 Cr | ₹14,911 Cr | ₹13,951 Cr |
What is the latest Total Expenditure of CIPLA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹19,483 Cr |
| Mar2024 | ₹17,763 Cr |
| Mar2023 | ₹17,251 Cr |
| Mar2022 | ₹14,911 Cr |
| Mar2021 | ₹13,951 Cr |
How is Total Expenditure of CIPLA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹19,483 Cr | 9.68 | |
| Mar2024 | ₹17,763 Cr | 2.96 | |
| Mar2023 | ₹17,251 Cr | 15.70 | |
| Mar2022 | ₹14,911 Cr | 6.88 | |
| Mar2021 | ₹13,951 Cr | - | |
Compare Total Expenditure of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹122,559.4 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
| MANKIND PHARMA | ₹89,972.9 Cr | -0.3% | -3.4% | -18.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.3% |
-0.6% |
3.9% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses